Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions to Sponsor CT Theatre Session, “Personalized Medicine: Improving Clinical Outcomes with Novel Fluid Management Strategies” Moderated by Renowned Cardiothoracic Surgeon Daniel Beckles, M.D., Ph.D., at the 2019 AATS Annual Meeting
EDEN PRAIRIE, Minn. , April 23, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced it will be sponsoring a CT Theatre Session at the American Association for Thoracic Surgery Annual Meeting on Monday, May 6, 2019 , 1:00-1:30 pm at the Metro Toronto Convention Center .
View HTML
Toggle Summary CHF Solutions Announces Launch of Ultrafiltration Program at Heart Hospital at Saint Francis
EDEN PRAIRIE, Minn. , April 16, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced that Heart Hospital at Saint Francis has launched an ultrafiltration program using the Aquadex FlexFlow® system to assist in the management of fluid overload in patients following cardiac surgery
View HTML
Toggle Summary CHF Solutions Announces Launch of Ultrafiltration Program at Oklahoma Heart Institute
EDEN PRAIRIE, Minn. , April 09, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced that Oklahoma Heart Institute in Tulsa, Oklahoma , has launched an ultrafiltration program using the Aquadex FlexFlow® system to assist in the management of fluid overload in patients following
View HTML
Toggle Summary CHF Solutions Submits Patent Application for Pediatric Use of Aquadex FlexFlow® System
EDEN PRAIRIE, Minn. , April 03, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the submission of a method of use application to the United States Patent and Trademark Administration for pediatric use of its Aquadex Flex Flow System.
View HTML
Toggle Summary CHF Solutions to Exhibit at The International Society for Heart and Lung Transplantation 2019 Annual Meeting and Scientific Sessions
EDEN PRAIRIE, Minn. , March 28, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced it will be exhibiting at the 2019 Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT ) on April 3-6, 2019 at the Lowes Meeting Complex in
View HTML
Toggle Summary Newly Published Article Demonstrates Ultrafiltration with CHF Solutions’ Aquadex FlexFlow® System Reduces Hospital Costs by Lowering 90-Day Re-admissions and Durations of Stay in Heart Failure Patients
EDEN PRAIRIE, Minn. , March 26, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced the publication of “ Ultrafiltration vs. Diuretics for Treatment of Fluid Overload in Patients with Heart Failure:  A  Hospital Cost Analysis ” in the Journal of Medical Economics showing that the
View HTML
Toggle Summary CHF Solutions, Inc. Announces Closing of $12.42 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
EDEN PRAIRIE, Minn. , March 12, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) today announced the closing of an underwritten public offering of units for gross proceeds of $12.42 million, which includes the full exercise of the underwriter's over-allotment option to purchase additional
View HTML
Toggle Summary CHF Solutions, Inc. Announces Pricing of $10.8 Million Underwritten Public Offering
EDEN PRAIRIE, Minn. , March 08, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) today announced the pricing of an underwritten public offering of units for gross proceeds of approximately $10.8 million prior to deducting underwriting discounts and commissions and offering expenses
View HTML
Toggle Summary CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , March 01, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS), today announced that effective February 25, 2019 , the independent directors approved five equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to five individuals
View HTML
Toggle Summary CHF Solutions, Inc. Announces 80% Revenue Growth for its Fourth Quarter and Provides Company Update
EDEN PRAIRIE, Minn. , Feb. 20, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter and year ended December 31, 2018 , which included the following highlights: Revenue for the fourth quarter ended December 31, 2018 increased 80.4 percent
View HTML